Praveen Rajendran Selected Research

Praveen Rajendran Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 08/2004
9	Colonic Neoplasms (Colon Cancer) 10/2022 - 01/2007
3	Polyps 03/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 02/2023 - 01/2019
1	COVID-19 02/2023
1	Cough 01/2022
1	Neoplasm Metastasis (Metastasis) 03/2021
1	Intestinal Neoplasms (Intestinal Cancer) 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021
1	Adenomatous Polyps 01/2021
1	Carcinogenesis 01/2017
1	Adenoma (Adenomas) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 08/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2013
1	Genomic Instability 01/2011
1	Carcinoma (Carcinomatosis) 12/2008
1	Adenocarcinoma 12/2008

Drug/Important Bio-Agent (IBA)

7	sulforaphaneIBA 03/2021 - 05/2011
6	Histones (Histone)IBA 03/2024 - 01/2011
5	Histone Deacetylase InhibitorsIBA 01/2016 - 05/2011
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 02/2023 - 06/2013
3	RNA (Ribonucleic Acid)IBA 03/2021 - 01/2017
3	histone deacetylase 3IBA 03/2021 - 01/2018
2	Sulindac (Copal)FDA LinkGeneric 01/2021 - 01/2017
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2021 - 01/2017
2	PhytochemicalsIBA 12/2020 - 01/2011
2	CateninsIBA 10/2020 - 01/2017
2	IsothiocyanatesIBA 01/2018 - 06/2013
2	Caspase 3 (Caspase-3)IBA 01/2017 - 12/2008
2	ChromatinIBA 01/2017 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2015 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 06/2013 - 01/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 06/2011 - 05/2011
2	Betulinic AcidIBA 02/2008 - 08/2004
1	Untranslated RNA (Noncoding RNA)IBA 01/2024
1	Antiviral Agents (Antivirals)IBA 02/2023
1	PolyphenolsIBA 10/2022
1	Small Interfering RNA (siRNA)IBA 10/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2022
1	Linoleic Acid (Linoleate)IBA 01/2022
1	Drug CombinationsIBA 03/2021
1	6-methylsulfinylhexyl isothiocyanateIBA 03/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Sirtuin 1IBA 10/2020
1	Androgen Receptors (Androgen Receptor)IBA 10/2020
1	(+)-JQ1 compoundIBA 01/2019
1	Lysine AcetyltransferasesIBA 01/2018
1	1H-tetrazole (tetrazole)IBA 01/2018
1	SurvivinIBA 01/2017
1	Cyclin D1IBA 01/2017
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 01/2017
1	tolfenamic acidIBA 01/2017
1	StilbenesIBA 01/2016
1	CyclinsIBA 01/2015
1	romidepsin (FK228)FDA Link 08/2014
1	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 06/2013
1	Co-Repressor ProteinsIBA 05/2011
1	NeuropeptidesIBA 12/2008
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2008
1	Tumor Suppressor Protein p53IBA 12/2008
1	Peptides (Polypeptides)IBA 12/2008
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 12/2008
1	DRF 7295IBA 12/2008
1	Substance PIBA 12/2008
1	Epidermal Growth Factor (EGF)IBA 12/2008
1	BombesinIBA 12/2008
1	thiazolyl blueIBA 01/2007
1	Amino Acids FDA Link 01/2007

Therapy/Procedure

1	Aftercare (After-Treatment) 03/2021
1	Colectomy 01/2021
1	Oral Administration 01/2018
1	Therapeutics 01/2007